blinatumomab,ponatinib
otsuka,amgen,takeda,astellas,incyte
['blina ', 'leusm', 'blinatumomab', 'ponatinib', 'ph+ all']
 presents on cohort of pts w/ newly-dx (or minimally-tx'ed) ph+ all treated w/ ponatinib + blinatumomab. 43% of pts age 60+. induction = ponatinib 30 mg/d w/ concomitant blina -&gt; pon later reduced to 15 mg/d. up to 5 cycles blina given. (1/2) #ash22 #leusm #allsm 
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????